Q3 2020 Holdings
Filed 2020-11-12 | 97 holdings | $107.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Outlook Therapeutics Inc | *W EXP 02/18/202 | 69012T115 | $17 | 129,500 | 0.0% |
| Cellectar Biosciences Inc | COM PAR | 15117F500 | $109 | 87,500 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR)Call | CALL | 21833P103 | $141 | 78,500 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $288 | 20,000 | 0.0% |
| Immatics N.v | *W EXP 07/01/202 | N44445117 | $350 | 100,000 | 0.0% |
| Nice SYS Inc | NOTE 1.250% 1/1 | 65366HAB9 | $681 | 250,000 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $785 | 22,480 | 0.0% |
| Solaredge Technologies Inc(SEDG) | COM | 83417M104 | $957 | 4,017 | 0.0% |
| Pandion Therapeutics Inc(PAND) | COM | 698340106 | $1.1K | 95,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $1.1K | 100,000 | 0.0% |
| Neubase Therapeutics Inc | COM | 64132K102 | $1.1K | 150,000 | 0.0% |
| Exicure Inc(XCUR) | COM | 30205M101 | $1.3K | 737,557 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.4K | 70,000 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $1.5K | 58,939 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $1.6K | 800,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $1.7K | 250,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $1.7K | 198,260 | 0.0% |
| Orgenesis Inc | COM NEW | 68619K204 | $2.0K | 398,803 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $2.1K | 112,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.0K | 240,140 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $3.0K | 310,000 | 0.0% |
| Perrigo Co PLC(PRGO) | SHS | G97822103 | $3.3K | 71,559 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $3.5K | 266,037 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $3.6K | 199,980 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $3.7K | 80,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $4.0K | 259,990 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $4.2K | 325,500 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $4.2K | 469,245 | 0.0% |
| Arya Sciences Acquisition Co | COM CL A | G3166W106 | $4.3K | 400,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $4.6K | 126,000 | 0.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.2K | 196,411 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $5.2K | 160,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $5.2K | 342,064 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.2K | 228,016 | 0.0% |
| Axovant Sciences LTD | COM | G0750W203 | $5.3K | 1,152,998 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.5K | 33,000 | 0.0% |
| Arya Sciences Acquistion Co | UNIT 06/09/2027 | G31655114 | $5.5K | 499,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $5.6K | 75,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $5.8K | 59,139 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $5.8K | 173,600 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $6.0K | 170,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $6.2K | 250,000 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $6.2K | 1,000,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $6.4K | 194,996 | 0.0% |
| Dominos Pizza Inc(DPZ) | COM | 25754A201 | $6.9K | 16,221 | 0.0% |
| Varonis SYS Inc(VRNS) | COM | 922280102 | $7.0K | 60,225 | 0.0% |
| Fiserv Inc(FISV) | COM | 337738108 | $7.2K | 70,246 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $7.5K | 188,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.5K | 510,000 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $7.5K | 245,000 | 0.0% |